XERSXeris Biopharma Holdings, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 23865
Ticker: XERS
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2018-06-21
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: XERS

Detail

Enriched 2026-08-14 20:47

Market cap: $1,547,899,397.94
Shares outstanding (class): 182,320,306
Shares outstanding (weighted): 182,320,306
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 435
Location: CHICAGO, IL
Homepage: https://www.xerispharma.com
Description: Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.

Market cap and share counts drift.

Funds holding this security

86 funds · 86 positions · $110.77M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$28.72M	0.00%	4,952,056 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$22.44M	0.03%	3,869,439 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$10.76M	0.01%	1,854,322 NS	FIGI
iShares Russell 2000 Growth ETF iShares Trust	IWO	$7.53M	0.06%	1,298,460 NS	FIGI
State Street(R) SPDR(R) S&P(R) Pharmaceuticals … SPDR SERIES TRUST	XPH	$5.66M	1.84%	975,649 NS	FIGI
College Retirement Equities Fund - Total Global… College Retirement Equities Fund	—	$3.44M	0.00%	592,980 NS	FIGI
iShares U.S. Pharmaceuticals ETF iShares Trust	IHE	$2.69M	0.27%	463,758 NS	FIGI
Fidelity Enhanced Small Cap ETF Fidelity Covington Trust	FESM	$2.42M	0.06%	417,452 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$2.32M	0.19%	400,814 NS	FIGI
Bridge Builder Small/Mid Cap Growth Fund Bridge Builder Trust	—	$2.16M	0.02%	372,451 NS	FIGI
Royce Smaller-Companies Growth Fund ROYCE FUND	—	$1.48M	0.83%	256,000 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$1.46M	0.03%	251,634 NS	FIGI
iShares Core S&P Total U.S. Stock Market ETF iShares Trust	ITOT	$1.29M	0.00%	222,716 NS	FIGI
VANGUARD STRATEGIC EQUITY FUND VANGUARD HORIZON FUNDS	—	$1.28M	0.01%	220,443 NS	FIGI
Principal U.S. Small-Cap ETF Principal Exchange-Traded Funds	PSC	$1.14M	0.06%	196,771 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERXERS
FIGI_COMPOSITEBBG012V1MG52
FIGI_SHARE_CLASSBBG012V1MG61
CIK0001867096
ISINUS98422E1038
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Xeris Biopharma is a pharmaceutical company developing and commercializing therapies, matching the SIC code for pharmaceutical preparations.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.